Effect of docetaxel on expression of eIF3a in human lung cancer A549 cell line

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 8, 2010, Pages 771-776

  Gong, Zhicheng ^a,b   Xu, Xiaojing ^a   Hou, Ruiying ^a   Guo, Yue ^c   Sheng, Feifeng ^a   Ouyang, Dongsheng ^a   Zhou, Honghao ^a   Liu, Zhaoqian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

tubulin; Docetaxel; Eukaryotic initial factor 3 a (eIF3a); Lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; EIF3A PROTEIN, HUMAN; INITIATION FACTOR 3; MESSENGER RNA; TAXOID; TUBULIN;

ARTICLE; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; EUKARYOTIC INITIATION FACTOR-3; HUMANS; LUNG NEOPLASMS; RNA, MESSENGER; TAXOIDS; TUBULIN;

EID: 77956679957     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.08.001     Document Type: Article

References (27)

1. Lyseng - Williamson K A , Fenlon C. Docetaxel : a review of its use in metastatic breast cancer [J] . Drugs , 2005, 65 (17) : 2513-2531.
2. Clarke S J , Rivory L P. Clinical pharmacokinetics of docetaxel [J] . Clin Pharmacokinet, 1999, 36 (2) :99-114.
3. Anonymous. Oncology Tools : Approved Claims for microtubule inhibitors. US Food and Drug Administration. 2006. www.archive.org.
4. Snyder J P , Nettles J H , Comett B , et al. The binding conformation of Taxol in beta - tubulin : a model based on electron crystallographic density [J]. Proc Natl Acad Sci USA, 2001, 98 (9): 5312-5316.
5. Rang H P , Dale M M , Ritter J M , et al. Pharmacology [M]. 5 th ed. London : Churchill Livingstone, 2003: 100-101.
6. Howard J , Hyman A A. Dynamics and mechanics of the microtubule plus end [J] . Nature , 2003 , 422 (6933) : 753-758. (Pubitemid 36514118)
7. Nogales E , Downing K H , Amos L A, et al. Tubulin and FtsZ form a distinct family of GTPases [J]. Nat Struct Biol, 1998, 5 (6) : 451-458. (Pubitemid 28265028)
8. Browning K S , Gallie D R , Hershey J W , et al. Unified nomenclature for the subunits of eukaryotic initiation factors 3 [J]. Trends Biochem Sci, 2001 , 26(5) :284. (Pubitemid 32436376)
9. Mamiko M , Nahum S , Shigeyuki Y, et al. Reconstitution reveals the functional core of mammalian eIF3 [J]. EMBO J, 2007 , 26(14) :3373-3383.
10. Dong Z, Zhang J T. Initiation factor eIF3 and regulation of mRNA translation , cell growth and cancer [J]. Oncology, 2006, 59(3) : 169-180. (Pubitemid 44294864)
11. Chaudhuri J , Chakrabarti A , Maitra U. Biochemical characterization of mammalian translation initiation factor 3 [J]. J Biol Chem, 1997, 272(49) : 30975-30983.
12. Zhang L L, Pan X Y , Hershey J W B. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells [J]. J Biol Chem, 2007, 282 (8): 5800.
13. Pincheria R , Chen Q , Zhang J T, et al. Identification of a 170-KDa protein over - expressed in lung cancer [J]. Br J Cancer, 2001 , 84 (11) : 1520-1527. (Pubitemid 32579345)
14. Dong Z Z, Zhang J T. EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression [J]. Mol Biol Cell, 2003, 14(9) : 3942-3951.
15. Pincheira R , Chen Q , Huang Z , et al. Two subcelluar localizations of eIF3 P170 and its interaction with membranebound micro - filaments : implication for alternative function of P170 [ J ]. Eur J Cell Biol, 2001 , 80 (6) : 410-418. (Pubitemid 32605784)
16. Dong Z Z , Liu L H , Han B G , et al. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth [J]. Oncogene, 2004 , 23(21): 3790-3801.
17. Eisenhauer E A , Vermorken J B. The taxoids : Comparative clinical pharmacology and therapeutic potential [J]. Drugs, 1998, 55 (1) : 5-30. (Pubitemid 28035122)
18. Dutcher S K. The tubulin fraternity : alpha to eta [ J ] . Curr Opin Cell Biol, 2001, 13 ( 1 ) : 49-54.
19. Bachmann F , Banziger R , Burger M M. Cloning of a novel protein over-expressed in human mammary carcinoma [J]. Cancer Res, 1997 , 57 (5 ) : 988-994. (Pubitemid 27098028)
20. Dong Z Z, Liu Z Q , Ping C , et al. Role of eIF3 a in regulating cell cycle progression [J]. Exp Cell Res, 2009, 315(11) : 1889-1894.
21. Chen G , Burger M M. p150 expression and its prognostic value in squamous - cell carcinoma of esophagus [J]. Int J Cancer, 1999 , 84 (2) : 95-100. (Pubitemid 29133817)
22. HAN Lifang , LIU Zhaoqian. Relationship between eIF3 subfamily and the development of tumor [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(10): 1195-1200.
23. SHEN Jie , LI Huihua , ZHANG Jianting , et al. Expression of eIF3S10 in lung cancer and its relationship with chemotherapy response [J]. Journal of Internationl Pathology and Clinical Medicine, 2006, 26 (5) : 369-371.
24. Lalande M. A reversible arrest point in the late G 1 phase of the mammalian cell cycle [J]. Exp Cell Res , 1990, 186 (2) : 332-339.
25. Mosca P J, Dijkwel P A, Hamlin J L. The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells [J]. Mol Cell Biol, 1992, 12 (10) : 4375-4383.
26. Wang G, Miskimins R, Miskimins W K. Mimosine arrests cells in Gl by enhancing the levels of p27 (Kip 1) [J]. Exp Cell Res, 2000, 254 (1): 64-71. (Pubitemid 30066732)
27. Hughes T A , Cook P R. Mimosine arrests the cell cycle after cells enter S-phase [J]. Exp Cell Res, 1996, 222 (2) : 275-280.